Lokau J, Garbers Y, Vicente M, Dittrich A, Meltendorf S, Lingel H
Front Immunol. 2025; 15():1488745.
PMID: 39835136
PMC: 11743636.
DOI: 10.3389/fimmu.2024.1488745.
Li K, Cai J, Jiang Z, Meng Q, Meng Z, Xiao H
Sci Rep. 2024; 14(1):18293.
PMID: 39112658
PMC: 11306327.
DOI: 10.1038/s41598-024-69429-w.
Jiang J, Wang J, Yao L, Lai S, Zhang X
Biophys Rep. 2023; 7(3):193-206.
PMID: 37287491
PMC: 10244797.
DOI: 10.52601/bpr.2021.200024.
Ziegler L, Lundstrom A, Havervall S, Thalin C, Gigante B
Cytokine. 2022; 159:156020.
PMID: 36057230
PMC: 9420722.
DOI: 10.1016/j.cyto.2022.156020.
Spanko M, Strnadova K, Pavlicek A, Szabo P, Kodet O, Valach J
Int J Mol Sci. 2021; 22(20).
PMID: 34681685
PMC: 8540903.
DOI: 10.3390/ijms222011027.
Role of IL-6 in the commitment of T cell subsets.
Korn T, Hiltensperger M
Cytokine. 2021; 146:155654.
PMID: 34325116
PMC: 8375581.
DOI: 10.1016/j.cyto.2021.155654.
Interleukin-6 controls recycling and degradation, but not internalization of its receptors.
Flynn C, Kespohl B, Daunke T, Garbers Y, Dusterhoft S, Rose-John S
J Biol Chem. 2021; 296:100434.
PMID: 33610555
PMC: 8010714.
DOI: 10.1016/j.jbc.2021.100434.
On the role of bacterial metalloproteases in COVID-19 associated cytokine storm.
Foldvari-Nagy L, Schnabel T, Dornyei G, Korcsmaros T, Lenti K
Cell Commun Signal. 2021; 19(1):7.
PMID: 33441142
PMC: 7805260.
DOI: 10.1186/s12964-020-00699-3.
Interleukin-6 signaling requires only few IL-6 molecules: Relation to physiological concentrations of extracellular IL-6.
Hansen M
Immun Inflamm Dis. 2020; 8(2):170-180.
PMID: 32103575
PMC: 7212196.
DOI: 10.1002/iid3.292.
Intragenic regulation of SOCS3 isoforms.
Klepsch O, Namer L, Kohler N, Kaempfer R, Dittrich A, Schaper F
Cell Commun Signal. 2019; 17(1):70.
PMID: 31238931
PMC: 6593527.
DOI: 10.1186/s12964-019-0379-6.
Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
Reeh H, Rudolph N, Billing U, Christen H, Streif S, Bullinger E
Cell Commun Signal. 2019; 17(1):46.
PMID: 31101051
PMC: 6525395.
DOI: 10.1186/s12964-019-0356-0.
Interleukin-6 secretion is limited by self-signaling in endosomes.
Verboogen D, Revelo N, Ter Beest M, van den Bogaart G
J Mol Cell Biol. 2018; 11(2):144-157.
PMID: 30016456
PMC: 6392102.
DOI: 10.1093/jmcb/mjy038.
The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P, Hansen S, Waetzig G, Akbarzadeh M, Lamertz L, Huber H
J Biol Chem. 2018; 293(18):6762-6775.
PMID: 29559558
PMC: 5936821.
DOI: 10.1074/jbc.RA117.001163.
Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells through Interleukin-6 Receptor Subunits Modulation.
Meley D, Heraud A, Gouilleux-Gruart V, Ivanes F, Velge-Roussel F
Front Immunol. 2017; 8:926.
PMID: 28861079
PMC: 5561017.
DOI: 10.3389/fimmu.2017.00926.
SorLA in Interleukin-6 Signaling and Turnover.
Larsen J, Petersen C
Mol Cell Biol. 2017; 37(11).
PMID: 28265003
PMC: 5440653.
DOI: 10.1128/MCB.00641-16.
IL-6 Production by TLR-Activated APC Broadly Enhances Aged Cognate CD4 Helper and B Cell Antibody Responses In Vivo.
Brahmakshatriya V, Kuang Y, Devarajan P, Xia J, Zhang W, Vong A
J Immunol. 2017; 198(7):2819-2833.
PMID: 28250157
PMC: 5360529.
DOI: 10.4049/jimmunol.1601119.
Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys.
Glassman P, Chen Y, Balthasar J
J Pharmacokinet Pharmacodyn. 2015; 42(5):527-40.
PMID: 26364301
DOI: 10.1007/s10928-015-9444-y.
Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex.
Lacroix M, Rousseau F, Guilhot F, Malinge P, Magistrelli G, Herren S
J Biol Chem. 2015; 290(45):26943-26953.
PMID: 26363066
PMC: 4646397.
DOI: 10.1074/jbc.M115.682138.
Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.
Carbone C, Fuchs S
J Cell Biochem. 2013; 115(1):8-16.
PMID: 23959845
PMC: 3856693.
DOI: 10.1002/jcb.24647.
Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting.
Shum A, Mahendradatta T, Taylor R, Painter A, Moore M, Tsoli M
Aging (Albany NY). 2012; 4(2):133-43.
PMID: 22361433
PMC: 3314175.
DOI: 10.18632/aging.100436.